Trials / Completed
CompletedNCT02323997
Human Papillomavirus in Cervical Cancer and Pre-cancer in Switzerland: The CIN3+Plus Study
Human Papillomavirus-Associated Cervical Neoplasia in Switzerland at the Start of a National Vaccination Programme: Crosssectional Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 767 (actual)
- Sponsor
- University of Bern · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the types of HPV in samples from women with cervical pre-cancer and cancer and gather information to help investigate the impact of HPV vaccination in Switzerland.
Conditions
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-12-01
- Completion
- 2016-05-01
- First posted
- 2014-12-24
- Last updated
- 2019-07-16
Locations
10 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02323997. Inclusion in this directory is not an endorsement.